|
|
 | | | |
- close
- close
- close
- close
MedQuist Holdings (MEDH) |
Suggest other news sources for this topic
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/c/ce/IPO.jpg': No such file or directory @ blob.c/OpenBlob/2480. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/c/ce/IPO.jpg/40px-IPO.jpg' @ convert.c/ConvertImageCommand/2800. |
This company completed an initial public offering (IPO) of its stock in 2010. View articles that reference this company. Recent IPOs: Globe Specialty Metals • LogMeIn • Invesco Mortgage Capital • Medidata • Chemspec |
MedQuist Holdings (NASDAQ:MEDH) provides system to digitally document clinical activity for the US Healthcare market. MedQuist's system converts physicians' dictation or narrative of patient interactions into an electronic record. This includes the speech recognition as well as document management and distribution. This helps the hospitals and clinics to efficiently and accurately automate the entire documentation process. MedQuist's services are used by more than 2,400 hospitals, clinics, and physicians in the US. This includes 40% of the hospitals that have more than 500 beds.[1]
The healthcare industry is expected to continue to grow from its current size of approximately $2.3T to $4.2T by 2018. Physicians have increasingly moved to outsource their documentation process so that they are able to focus on spending more time with their existing or new patients.[2] The US government passed the Health Information Technology for Economic and Clinical Health Act (HITECH) which will distribute $19.2B in government subsidies to implement Electronic Health Records by 2019. The services offered by MedQuist helped to fulfill this exact need. By transcribing narratives into electronic records.[3]
The company's initial public offering of stock on the NASDAQ occurred on February 3, 2011. The company offered 4.5M shares each for $8. The company had originally planned to sell 7.8M shares within the range of $10-$12. However, the company decreased the deal size and decreased the share price. The original deal would have been worth $85.8M at the center of the range, but the offering ended up being worth $36M due to the revision. The lead underwriters of the deal were Lazard (LAZ), Macquarie Capital, and RBC Capital Markets.[4]
The company's revenue for the full year 2009 was $372M. This was a 92% increase over the previous year's full year revenue. For the first 9 months of 2010, the company reported a revenue of $317M. In 2009, the company reported a net income of $735K. During the first 9 months of 2010, the company reported a net income of $6.4M[5]
References
- ↑ MEDH S-1/A 2011 PROSPECTUS SUMMARY "Overview" pg 1
- ↑ MEDH S-1/A 2011 PROSPECTUS SUMMARY "Our Industry" pg 2
- ↑ EPOC S-1/A 2011 PROSPECTUS SUMMARY "Market Opportunity" pg 1-2
- ↑ Renaissance Capital - IPO Home "MedQuist Holdings prices IPO at $8, below the range" 4 Feb 2011
- ↑ MEDH S-1/A 2011 PROSPECTUS SUMMARY "Overview" pg 1
| |||||||
